Modification of Cytokine Networks Induced in the Host by Intestinal Bacteria Producing Exotoxins

References

• Sansonetti PJ, Phalipon A. M cells as ports of entry for enteroinvasive pathogens: mechanisms of interaction, conse-quences for disease process. Semin Immunol 1999; 11: 193–203.
   PubMed Web of Science ®Google Scholar
• Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, Moryzy-cka-Wrobleska E Kagnoff MF. A distinct array of proinflammatory cytokines is expressed in human colon ep-ithelial cells in response to bacterial invasion. J Clin Invest 1995; 95: 55–65.
   Google Scholar
• McAlindon ME, Mahida YR. Cytokines and the gut. Eur J Gastroenterol Hepatol 1997; 9: 1045–50.
   PubMed Web of Science ®Google Scholar
• Henderson B, Wilson M, Wren B. Are bacterial exotoxins cytokine network regulators? Trends Microbiol 1997; 5: 454.
   Google Scholar
• Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787–93.
   Google Scholar
• Ada GL. The immunological principles of vaccination. Lancet 1990; 335: 523–6.
   PubMed Web of Science ®Google Scholar
• Wilson M, Seymour R, Henderson B. Bacterial perturbation of cytokine networks. Infect Immun 1998; 66: 2401–9.
   PubMed Web of Science ®Google Scholar
• Henderson B, Poole S, Wilson M. Microbial/host interactions in health and disease: who controls the cytokine network? Immunopharmacology 1996; 35: 1–21.
   Google Scholar
• Sadlack B, Men H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75: 253–61.
   PubMed Web of Science ®Google Scholar
• Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-defrient mice develop chronic enterocolitis. Cell 1993; 75: 263–74.
   Google Scholar
• Klaproth JM, Donnenberg MS, Abraham JM, Mobley HL, James SP. Products of enteropathic Escherichia coli inhibit lymphocyte activation and lymphokine production. Infect Immun 1995; 63: 2248–54.
   Google Scholar
• Henderson B, Poole S, Wilson M. Bacterial modulins: a novel class of virulence factor which causes host tissue pathology by inducing cytokine synthesis. Microbiol Rev 1996; 60: 316–41.
   Google Scholar
• Herman A, Kappler JVK, Marrack P, Pullen AM. Superanti-gens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol 1991; 9: 745.
   PubMed Web of Science ®Google Scholar
• MacDonald HR, Baschieri S, Lees RK. Clonal expansion precedes anergy and death of Vb8 + peripheral T cells re-sponding to staphylococcal enterotoxin B in vivo. Eur J Immunol 1991; 21: 1963.
   Google Scholar
• Herrmann T, Baschieri S, Lees RK, MacDonald HR. In vivo responses of CD4 + and CD8 + cells to bacterial superanti-gens. Eur J Immunol 1992; 22: 1935.
   Web of Science ®Google Scholar
• Fuleihan R, Mourad W, Geha RS, Chatila T. Engagement of MCH-classII molecules by staphylococcal exotoxins delivers a comitogenic signal to human B cells. J Immunol 1991; 146: 1661–6.
   Web of Science ®Google Scholar
• Scholl PR, Trede N, Chatila TA, Geha RS. Role of protein tyrosine phosphorylation in monokine induction by the staphylococcal superantigen toxic shock syndrome toxin-1. J Immunol 1992; 148: 1429–33.
   Web of Science ®Google Scholar
• Stiles BG, Bavari S, Krakauer T, Ulrich RG. Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccha-ride: major histocompatibility complex class II molecule de-pendency and cytokine release. Infect Immun 1993; 61: 5333–8.
   PubMed Web of Science ®Google Scholar
• Leung DYM, Gately M, Trumble A, Ferguson-Darnell B, Schlievert M, Picker U. Bacterial superantigens induce T-cell expression of the skin-selective homing receptor, the cuta-neous lymphocyte-associated antigen, via stimulation of in-teleukin 12 production. J Exp Med 1995; 181: 747–53.
   Google Scholar
• Grossman D, Lamphear JG, Mollick JA, Betley MJ, Rich RR Dual roles for class II major histocompatibility complex molecules in staphylococcal enterotoxin-induced cytokine production and in vivo toxicity. Infect Immun 1992; 60: 5190–6.
   PubMed Web of Science ®Google Scholar
• Beezhold DH, Best GK, Bonventre PF, Thompson M. Syner-gistic induction of IL-1 by endotoxin and toxic shock syn-drome toxin-1 using rat macrophages. Infect Immun 1987; 55: 2865–9.
   Web of Science ®Google Scholar
• Henne E, Campbell WH, Carlson E. Toxic shock syndrome toxin 1 enhances synthesis of endotoxin induced tumor necro-sis factor in mice. Infect Immun 1991; 59: 2929–33.
   Google Scholar
• Marrack P, Balckman H, Kushnir E, Kappler J. The toxicity of staphylococcal enterotoxin B in mice is mediated by T-cells. J Exp Med 1990; 171: 455.
   PubMed Web of Science ®Google Scholar
• Bhadki S, Muhly M, Korom S, Schmidt G. Effect of E. coli haemolysin of human monocytes. Cytocidal action and stimu-lation of Interleukin 1 release. J Clin Invest 1990; 85: 1746–53.
   Google Scholar
• Xu-Amano J, Kiyono H, Jackson RJ, et al. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med 1993; 178: 1309–20.
   Google Scholar
• Okahashi N, Yamamoto M, Vancott JL, et al. Oral immu-nization of interleukin-4 (IL-4) knockout mice with a recom-binant Salmonella strain or cholera toxin reveals that CD4 + Th2 cells producing IL-6 and IL-10 are associated with mu-cosal immunoglobulin A responses. Infect Immun 1996; 64: 1516–25.
   PubMed Web of Science ®Google Scholar
• Klimpel GR, Asuncion M, Haithcoat J, Niesel DW. Cholera toxin and Salmonella typhimurium induce different cytokine profiles in the gastrointestinal tract. Infect Immun 1995; 63: 1134–7.
   PubMed Web of Science ®Google Scholar
• Bromander AK, Kjerrulf M, Holgren J, Lycke N. Cholera toxin enhances alloantigen presentation by cultured intestinal epithelial cells. Scand J Immunol 1993; 37: 452–8.
   Web of Science ®Google Scholar
• Nashar TO, Webb HM, Eaglestone S, Williams NA, Hirst TR. Potent immunogenicity of the B subunits of Escherichia coli heat labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets. Proc Natl Acad Sci USA 1996; 93: 226–30.
   Google Scholar
• Louis CB, Kaye SA, Boyd B, Lingwood CA, Oibrig TG. Shiga toxin associated haemolytic-uremic syndrome: com-bined cytotoxic effects of shiga toxin, interleukin 1B and human necrosis factor a on human vascular endothelial cells in vitro. Infect Immun 1991; 59: 4173–9.
   Google Scholar
• Tesh UL, Ramegovda B, Samuel JE. Purified Shiga-like tox-ins induce expression of pro-inflammatory cytokines from murine peritoneal macrophages. Infect Immun 1994; 62: 5085–94.
   Google Scholar
• van de Kar NC, Kooistra T, Vermeer M, Lesslauer W, Monnens LA, van Hinsbergh VW. Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor and protein kinase C. Blood 1995; 85: 734–43.
   Google Scholar
• Van Tassell RL, Lyerly DM, Wilkins TD. Purification and characterization of an enterotoxin from Bacteroides fragilis. Infect Immun 1992; 60: 175–81.
   Google Scholar
• Sanfilippo L, Li CKF, Seth R, Baldwin J, Menozzi MG, Mahida YR. Bacteroides fragilis enterotoxin induces the ex-pression of interleukin-8 and transforming growth factor beta by human colonic epithelial cells. Clin Experiment Immunol 2000; 119: 45–63.
   Web of Science ®Google Scholar
• Leal-Berumen I, Snider DP, Barajas-Lopez C, Marshall JS. Cholera toxin increases IL-6 synthesis and decreases TNF-ii production by rat peritoneal mast cells. J Immunol 1996; 156: 316–21.
   Google Scholar
• Staugas REM, Harvey DP, Ferrante A, Nandoskar M, Al-lison AC. Induction of tumor necrosis factor (TNF) and interleukin-1 (IL-1) by Pseudomonas aeruginosa and endotoxin A-induced suppression of lympho proliferation and TNF, lymphotoxin, gamma interferon, and IL-1 production in hu-man leukocytes. Infect Immun 1992; 60: 3162–8.
   Google Scholar
• George WL, Finegold SM. Clostridia in the human gas-trointestinal flora. In: Bothell° SP (Ed.), Clostridia in Gas-trointestinal Disease. SP CRC Press Inc, Boca Raton, Florida 1985; pp. 1–39.
   Google Scholar
• Berg RD. The indigenous gastrointestinal microflora. Trends Microbiol 1996; 4: 430.
   PubMed Web of Science ®Google Scholar
• Cleary RK. Clostridium difficile-associated diarrhea and coli-tis: clinical manifestations, diagnosis, and treatment. Dis Colon Rectum 1998; 41: 1435–49.
   PubMed Web of Science ®Google Scholar
• Larson HE, Price AB, Honor P, Bothell° SP. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1978; i: 1063–6.
   Google Scholar
• Viscidi R, Laughon BE, Yolken R, et al. Serum antibody response to Toxin A and B of Clostridium difficile. J Infect Dis 1983; 148: 93–100.
   PubMed Web of Science ®Google Scholar
• Kelly CP. Immune response to Clostridium difficile infection. Eur J Gastoenterol Hepatol 1996; 8: 1048.
   PubMed Web of Science ®Google Scholar
• Borriello SP. Pathogenesis of Clostridium difficile infection. J Antimicrob Chemother 1998; 41 (Suppl C): 13–9.
   Google Scholar
• Von Eichel-Streiber C, Boquet P, Sauerbom M, Thelestam M. Large clostridial cytotoxins-a family of glycosyltrans-ferases modifying small GTP-binding proteins. Trends Micro-biol 1996; 4: 375.
   Google Scholar
• Pothoulakis C. Pathogenesis of Clostridium difficile-associated diarrhoea. J Gastroenterol Hepatol 1996; 8: 1041–7.
   Google Scholar
• Steiner TS, Flores CA, Pizarro TT, Guerrant RL. Fecal lactoferrin, interleukin-lbeta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis. Clin Diagn Lab Immun 1997; 4: 719–22.
   PubMedGoogle Scholar
• Castagliuolo I, Riegler M, Pasha A, et al. Neurokinin-1 (NK-1) receptor is required in Clostridium difficile-induced enteritidis. J Clin Invest 1998; 101: 1547–50.
   PubMed Web of Science ®Google Scholar
• Rocha MFG, Maia MET, Bezerra LRPS, et al. Clostridium difficile toxin A induces the release of neutrophil chemotactic factors from rat peritoneal macrophages: role of interleukin-113, tumor necrosis, factor alpha, and leukotrienes. Infect Immun 1997; 65: 2740–6.
   PubMed Web of Science ®Google Scholar
• Souza MH, Melo-Filho AA, Rocha MF, et al. The involve-ment of macrophage-derived tumour necrosis factor and lipoxygenease products on the neutrophil recruitment induced by Clostridium difficile toxin B. Immunology 1997; 91: 281–8.
   PubMed Web of Science ®Google Scholar
• Mahida YR, Makh S, Hyde S, Gray T, Bothell° SP. Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment. Gut 1996; 38: 337–47.
   Google Scholar
• Branka JE, Vallette G, Jarry A, et al. Early functional effects of Clostridium difficile toxin A on human colonocytes. Gas-troenterology 1997; 112: 1887–94.
   Web of Science ®Google Scholar
• Mahida YR, Galvin A, Makh S, et al. Effect of Clostridium difficile toxin A on human colonic lamina propria cells: early loss of macrophages followed by T-cell apoptosis. Infect Immun 1998; 66: 5462–9.
   Web of Science ®Google Scholar
• Rocha MFG, Soares AM, Flores CA, et al. Intestinal secre-tory factor released by macrophages stimulated with Clostrid-hen difficile toxin A: role of Interleukin 113. Infect Immun 1998; 66: 4910–6.
   Web of Science ®Google Scholar
• Linevsky JK, Pothoulakis C, Keates S, et al. IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytes. Am J Physio11997; 273 (6pt + 1): G1333–40.
   Google Scholar
• Melo-Filho AA, Souza MH, Lyerly DM, Cunha FQ, Lima AA, Ribeiro RA. Role of tumor necrosis factor and nitric oxide in the cytotoxic effects of Clostridium difficile toxin A and toxin B on macrophages. Toxicon 1997; 35: 743–52.
   Google Scholar
• Flegel WA, Muller F, Daubener W, Fisher HG, Hadding U, Northoff H. Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B. Infect Immun 1991; 59: 3659–66.
   PubMed Web of Science ®Google Scholar
• Castagliuolo I, Keates AC, Wang CC, et al. Clostridium difficile Toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells. J Im-munol 1998; 160: 6039–45.
   PubMed Web of Science ®Google Scholar
• Calderon GM, Torres Lopez J, Lin TJ, et al. Effects of toxin A from Clostridium difficile on mast cell activation and sur-vival. Infect Immun 1998; 66: 2755–61.
   Web of Science ®Google Scholar
• Wallace FM, Mach AS, Keller AM, Lindsay JA. Evidence for Clostridium perfringens enterotoxin (CPE) inducing a mito-genic and cytokine response in vitro and a cytokine response in vivo. Curr Microbiol 1999; 38: 96–100.
   PubMed Web of Science ®Google Scholar
• Krakauer T, Fleisher B, Stevens DL, McClane BA, Stiles BG. Clostridium perfringens enterotoxin lacks superantigenic activ-ity but induces an interleukin-6 response from human periph-eral blood mononuclear cells. Infect Immun 1997; 65:3485–8.
   Google Scholar
• Nagata K, Okamura H, Kunitoh D, Uemura T. Mitogenic activity of Clostridium perfringens enterotoxin in human pe-ripheral lymphocytes. J Vet Med Sci 1997; 59: 5–8.
   Web of Science ®Google Scholar
• Bryant AE, Stevens DL. Phospholipase C and perfringolysin 0 from Clostridium perfringens upregulate endothelial cell-leukocyte adherence molecule 1 and intracellular leukocyte adherence molecule 1 expression and induce interleukin-8 synthesis in cultured human umbilical vein endothelial cells. Infect Immun 1996; 64: 358–62.
   PubMed Web of Science ®Google Scholar
• Gustafson-Svard C, Tagesson C, Boll RM, Kald B. Tumor necrosis factor-alpha potentiates phospholipaseA2-stimulated release and metabolism of arachidonic acid in cultured intesti-nal epithelial cells (INT 407). Scand J Gastroentero11993; 28: 323.
   Google Scholar
• Wang GR, Chen HY, Chen CH, Yeh MY, Mikami Y. Immunopotentiating activity of Clostridium butyricum in mice. Life Sci 1996; 20: 101–9.
   Google Scholar
• Chen HY, Wu SL, Yeh MY, Chen CF, Mikami Y, Wu JS. Antimetastatic activity induced by Clostridium butyricum and characterization of effectors cells. Anticancer Res 1993; 13: 107–11.
   Web of Science ®Google Scholar